Enhancing Fenbendazole Bioavailability Through Acid Cocrystallization
The cocrystal solubility comparison plot from this study illustrates a highly promising chemical strategy to solve the poor bioavailability bottleneck of fenbendazole by pairing it with organic acid coformers:
Fenbendazole Saturation Solubility Comparison
Pure Fenbendazole (Baseline): Exhibits an exceptionally low aqueous saturation solubility of 0.210 mg/mL, highlighting why the raw drug suffers from poor intestinal absorption.
Cinnamic Acid Cocrystal: Increases saturation solubility 4.0-fold to 0.845 mg/mL.
Benzoic Acid Cocrystal: Increases saturation solubility 4.7-fold to 0.985 mg/mL.
Salicylic Acid Cocrystal: Achieves the highest solubility boost, increasing baseline solubility 5.0-fold to 1.052 mg/mL.
Why Cocrystallization Matters for Clinical Translation
Because fenbendazole is a BCS Class II compound (low solubility, high permeability), its therapeutic absorption in the human digestive tract is physically limited by how fast it can dissolve in gastric and intestinal fluids.
By engineering a cocrystal—where fenbendazole and an FDA-approved coformer (like salicylic acid) are bound together in a single crystalline lattice—scientists can alter the drug’s physical dissolution rate without changing its chemical structure. This 5-fold increase in solubility allows a significantly higher concentration of active fenbendazole to dissolve, cross the intestinal epithelium, and enter the bloodstream to target distant tumors.
The Cellular Connection: The Dual Role of Eosinophils
Interestingly, this document also contains a detailed immunological illustration that visually maps the connection between fighting parasites and fighting cancer.
It highlights how activated eosinophils utilize the exact same highly toxic granule proteins—including Major Basic Protein (MBP), Eosinophil Cationic Protein (ECP), Eosinophil-Derived Neurotoxin (EDN), and Eosinophil Peroxidase (EPO)—to target and destroy both large parasitic worms and malignant cancer cell membranes.
Additional information from second paper:
Source:
Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways
Sci. Rep. 2018 Aug 9;8(1):11926. doi: 10.1038/s41598-018-30158-6
PMCID: PMC6085345 PMID: 30093705
Would be good to know the corresponding Cmax (peak blood concentration), AUC (total systemic exposure), and ideally tissue concentrations. Sometimes a several-fold improvement in dissolution produces a much smaller increase in systemic exposure; sometimes it produces a substantial increase. Full disclosure, I checked with chatgpt (that was a copy paste).
I premix fenben with an oil to help with absorption. Should I get a bottle of salicylic acid and mix that in instead? In addition? Probably instead.